Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yudi Zhu

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Biomed Research International|June 30, 2020
PLP2 Expression as a Prognostic and Therapeutic Indicator in High-Risk Multiple MyelomaHua Bai, Yudi Zhu, Peipei Xu, et al.
Journal of Biosciences|June 7, 2018
Inhibition of miR-1247 on cell proliferation and invasion in bladder cancer through its downstream target of RAB36Yudi Zhu, Shaosi Liang, Huafeng Pan, et al.
Molecular Medicine Reports|January 13, 2018
MicroRNA‑136 inhibits prostate cancer cell proliferation and invasion by directly targeting mitogen‑activated protein kinase kinase 4Yudi Zhu, Siliang Shao, Huafeng Pan, et al.
Experimental and Therapeutic Medicine|June 8, 2017
Regulation of the angiotensin II-p22phox-reactive oxygen species signaling pathway, apoptosis and 8-oxoguanine-DNA glycosylase 1 retrieval in hyperoxia-induced lung injury and fibrosis in ratsYu Wang, Yuxi Zhu, Yudi Zhu, et al.
Biomimetics (Basel, Switzerland)|November 26, 2025
A Two-Stage Reinforcement Learning Framework for Humanoid Robot Sitting and Standing-UpXisheng Jiang, Shihai Zhao, Yudi Zhu, et al.
Experimental and Therapeutic Medicine|March 8, 2021
Prognostic value of miR-339-5p in patients with prostate cancer and its effects on tumor progressionHuafeng Pan, Xin Rui, Wei Wei, et al.
World Journal of Surgical Oncology|March 21, 2018
Transcription factor FoxM1 is the downstream target of c-Myc and contributes to the development of prostate cancerHuafeng Pan, Yudi Zhu, Wei Wei, et al.
Molecular Medicine Reports|May 5, 2023
[Retracted] MicroRNA‑136 inhibits prostate cancer cell proliferation and invasion by directly targeting mitogen‑activated protein kinase kinase 4Yudi Zhu, Siliang Shao, Huafeng Pan, et al.
Technology and Health Care : Official Journal of the European Society for Engineering and Medicine|September 19, 2022
Spring damping based control for a novel lower limb rehabilitation robot with active flexible training planningJie Hu, Qiaoling Meng, Yudi Zhu, et al.
Biomimetics (Basel, Switzerland)|February 25, 2025
Exploiting Arch-like Foot Structure for Knee-Extended Walking in Bipedal RobotsYudi Zhu, Zhiyuan Liang, Jun Tang, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Biomed Research International|June 30, 2020
PLP2 Expression as a Prognostic and Therapeutic Indicator in High-Risk Multiple MyelomaHua Bai, Yudi Zhu, Peipei Xu, et al.
Journal of Biosciences|June 7, 2018
Inhibition of miR-1247 on cell proliferation and invasion in bladder cancer through its downstream target of RAB36Yudi Zhu, Shaosi Liang, Huafeng Pan, et al.
Molecular Medicine Reports|January 13, 2018
MicroRNA‑136 inhibits prostate cancer cell proliferation and invasion by directly targeting mitogen‑activated protein kinase kinase 4Yudi Zhu, Siliang Shao, Huafeng Pan, et al.
Experimental and Therapeutic Medicine|June 8, 2017
Regulation of the angiotensin II-p22phox-reactive oxygen species signaling pathway, apoptosis and 8-oxoguanine-DNA glycosylase 1 retrieval in hyperoxia-induced lung injury and fibrosis in ratsYu Wang, Yuxi Zhu, Yudi Zhu, et al.
Biomimetics (Basel, Switzerland)|November 26, 2025
A Two-Stage Reinforcement Learning Framework for Humanoid Robot Sitting and Standing-UpXisheng Jiang, Shihai Zhao, Yudi Zhu, et al.
Experimental and Therapeutic Medicine|March 8, 2021
Prognostic value of miR-339-5p in patients with prostate cancer and its effects on tumor progressionHuafeng Pan, Xin Rui, Wei Wei, et al.
World Journal of Surgical Oncology|March 21, 2018
Transcription factor FoxM1 is the downstream target of c-Myc and contributes to the development of prostate cancerHuafeng Pan, Yudi Zhu, Wei Wei, et al.
Molecular Medicine Reports|May 5, 2023
[Retracted] MicroRNA‑136 inhibits prostate cancer cell proliferation and invasion by directly targeting mitogen‑activated protein kinase kinase 4Yudi Zhu, Siliang Shao, Huafeng Pan, et al.
Technology and Health Care : Official Journal of the European Society for Engineering and Medicine|September 19, 2022
Spring damping based control for a novel lower limb rehabilitation robot with active flexible training planningJie Hu, Qiaoling Meng, Yudi Zhu, et al.
Biomimetics (Basel, Switzerland)|February 25, 2025
Exploiting Arch-like Foot Structure for Knee-Extended Walking in Bipedal RobotsYudi Zhu, Zhiyuan Liang, Jun Tang, et al.
Pageof 2